Abstract
Multiple primary malignancies especially in the head and neck region is no longer a rare occurrence and the prevalence is increasing. They were described as synchronous when the malignancies present within 6 months of another or metachronous tumors if the subsequent malignancy presents 6 months later. Many etiologies had been hypothesised including similar carcinogens exposure, genetic susceptibility and mutation, immunodeficiency or treatment of the index tumor. Among the hypotheses, the most accepted theory was field cancerisation in which the occurrence of multiple primaries in the aerodigestive tract was due to persistent exposure of similar carcinogens through inhalation or oral intake . However the co-incidence of thyroid and aerodigestive malignancies is relatively low. Hereby we would like to report a case of a 74 years old lady with known esophageal squamous cell carcinoma presented with metachronous laryngeal squamous cell carcinoma and papillary micro carcinoma of thyroid.
Author Contributions
Copyright© 2020
Syiao Wei Ng, et al.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Competing interests The authors have declared that no competing interests exist.
Funding Interests:
Citation:
Introduction
Development of second or multiple primary tumors is often devastating for the patient and challenging to the clinicians due to the difficulties in management and treatment of the subsequent malignancies. Patients with history of treated head and neck cancer have tendency of developing second (3-5%), third (0.5%) and fourth (0.3%) primary tumor later in life, most commonly seen in head and neck, lungs or esophagus.
Discussion
Based on our literature search, triple primary malignancies were rare and this is the first combination of laryngeal, esophageal and thyroid cancers. In view of diagnosis of esophageal cancer was made in 2018, while the laryngeal and thyroid cancers were diagnosed in 2020, the latter two were described as metachronous tumors. The laryngeal and thyroid lesions, in relation to one other, would be synchronous tumours. Patients with squamous cell carcinoma of the aerodigestive tract have a high tendency to develop second primary malignancies. A 15-year study by San-Chi Chen et al. showed esophageal cancer patients had increased tendency to develop a second primary tumor, most frequently at aerodigestive tract, especially head and neck, lungs and stomach. Regular surveillance using FNPLS before and after treatment of esophageal cancer is important to diagnose second primary malignancy early. The subsequent primary tumors usually carried poorer prognosis by being more aggressive, more resistant to treatment and spread early hence requiring prompt treatment; however unfortunately they were frequently missed and were diagnosed at late stage. Our patient was diagnosed to have laryngeal cancer stage 3 during her 6 monthly follow up for tracheostomy tube change. She was immediately planned for total laryngectomy however her case was complicated with previous history of Mc Keown esophagectomy and chemoradiotherapy resulting in delay in operation. The upper gastrointestinal surgeon was concerned that, after esophagectomy, stomach pull up was done and the gastric conduit was at the level of C6-C7. This might be encountered during total laryngectomy and interfered with the reconstruction of neopharynx. On the other hand, total laryngectomy may compromise blood supply of gastric conduit. Hence her case was discussed with Senior Head and Neck Consultant and proceeded for total laryngectomy and total thyroidectomy. Thyroidectomy is routinely advocated as part of total laryngectomy especially in advanced laryngeal cancer with thyroid invasion. With the advance of healthcare and technology, the longevity of the people is extended and the elderly population has been growing especially in the developed countries. In medical literature, the elders are defined as more than 70 years old and they are divided into three categories based on the National Institute of Aging, young old (65-74 years old), older old (75-84 years old) and oldest old (85 and above). The management of multiple primary malignancies in elderly population is challenging due to progressive reduction of functional reserve of multiple organs, enhanced susceptibility to side effects of chemoradiotherapy and surgical complications and greater association with chronic diseases. This was further complicated by fluctuations in social support and financial resources.